Skip to content

Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

Effect of Exercise on Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03445351
Acronym
PLHA
Enrollment
17
Registered
2018-02-26
Start date
2013-01-20
Completion date
2016-09-13
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder Sleep, HIV/AIDS and Infections, Lipodystrophy

Keywords

Exercise Therapy;, Sleep;, ; Immune Markers;, HIV

Brief summary

Aim: Evaluate the influence of exercise, in different times, on quality of life, sleep and clinical parameters in people living with HIV/AIDS (PLHA). Methods: Intervention study, prospective.

Detailed description

Aim: Evaluate the influence of exercise, in different times, on quality of life, sleep and clinical parameters in people living with HIV/AIDS (PLHA). Methods: Intervention study, prospective, a cohort with 17 PLHA participants of the exercise program, higher than 18 years, under antiretroviral therapy with CD4+ ≥ 350/mm3. Research Ethical Committee of the institution approved the study and the participants sign the informed consent and informed. All subjects underwent an exercise program in conformity to American College of Sports Medicine, 3 times per week during 40 minutes. Were evaluated the quality of life (QoL) with the Quality of Life - HAT - QoL and the sleep quality (SQ) with the Pittsburg questionnaire. The subjects were evaluated before the start of exercise program and in three times: short-term (2 to 4 months), medium-term (between 5 and 17 months) and long-term (between 18 to 25 months).

Interventions

OTHERAerobic, resistance and concorrent.

All protocols followed the American College of Sports Medicine (ACSM) guidelines , with frequency of three times per week, duration between 40-50 minutes, low to high intensity, modified according to the physical needs of each participant, respecting the physical training principles.

Sponsors

JULIANY DE SOUZA ARAUJO
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Intervention study, prospective, a cohort with 17 PLHA participants of the exercise program

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Must have age ≥ 18 years old; * diagnosis of HIV/AIDS; * use of antiretroviral therapy; * Must have lymphocyte T CD4+ cell count ≥ 350 cel/mm3 * Must have physical fitness by the assistant physician.

Exclusion criteria

* pregnancy; * severe hearing deficiency.

Design outcomes

Primary

MeasureTime frameDescription
Quality of life24 MONTHSA translation adapted and validated for Brazil of the HIV/AIDS Targeted Quality of Life questionnaire (HAT-QoL) developed by Holmes & Shea, was used . The HAT-QoL present 34 questions divided in nine domains: Overall Function (OVEFUN), Life Satisfaction (LISA), Health Worries (HEAWOR), Financial Worries (FINWOR), Medication Concerns (MEDCON), HIV Mastery (HIVMAS), Disclosure Worries (DISWOR), Provider Trust (PROTRU) and Sexual Function (SEXFUN). The score ranges from 0 to 100. The responses have a five-point Likert scale: all the time, most of the time, part of the time, little time and never. In each domain, zero is the lowest score and 100 the best score possible. The higher the score, the lower the impact of HIV infection on the individuals' quality of life.

Secondary

MeasureTime frameDescription
Quality of sleep24 MONTHSFor the QoS the Pittsburgh Sleep Quality Index validated for Brazilian population, was applied. This scale is composed of 19 items that evaluate aspects related to sleep latency, duration, usual efficiency, sleep disturbance, use of hypnotic drugs and daytime dysfunction in the last month. Scores smaller than 5 define good sleep quality; values ranging between 6 to 11 bad sleep quality and values greater than 11 sleep disturbance. To answer the questionnaires, the subjects were oriented to think about the QoL and QoS in the previous four weeks.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026